DEF: Privia Health Group Sets Date for 2025 Annual Stockholders Meeting, Outlines Key Proposals

Privia Health Group announces its 2025 Annual Meeting of Stockholders to be held virtually on May 21, 2025, featuring director elections, executive compensation advisory vote, and ratification of the independent accounting firm.

Summary

• Privia Health Group, Inc. will hold its 2025 Annual Meeting of Stockholders on May 21, 2025, as a virtual meeting.
• Stockholders of record as of March 24, 2025, are eligible to vote.
• The meeting will include the election of three Class III directors (Pamela Kimmet, Patricia Maryland, and Shawn Morris) to serve until the 2028 annual meeting.
• There will be an advisory vote on the compensation of the named executive officers (NEOs).
• Stockholders will also vote to ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the year ending December 31, 2025.
• Adam Boehler, a board member since 2023, will not be standing for re-election, reducing the board size to nine members.
• The board recommends voting 'FOR' the election of the director nominees, the advisory vote on executive compensation, and the ratification of the accounting firm appointment.

Sentiment

Score: 7

Explanation: The document presents a balanced view of the company's governance and performance, with a focus on positive developments and future commitments. The sentiment is moderately positive.

Positives

• The company is committed to strong corporate governance, with a supermajority independent board and fully independent committees.
• The roles of Chief Executive Officer and Chair of the Board are separate.
• The company has seated five new directors since its initial public offering in 2021, demonstrating a commitment to board refreshment.
• The company has an active stockholder engagement program and values feedback from stockholders.
• The company has adopted an anti-hedging and -pledging policy that applies to directors and executive officers.
• The company structures compensation with a strong emphasis on performance-based, at-risk compensation.
• The Compensation Committee engages an independent compensation consultant to advise them and evaluate compensation relative to the market and peer group.
• The company has adopted a robust clawback policy for incentive compensation, beyond the requirements of the SEC.

Risks

• The document does not explicitly mention any specific risks, but it does allude to the potential for vulnerability to stockholders with short-termist demands.
• The document mentions the volatility in the healthcare sector underscores the need for enhanced continuity of business strategies and policies.

Future Outlook

The company is committed to evolving its Board structure and other corporate governance practices to mirror the evolution of the Company’s stockholder base and business.

Management Comments

• On behalf of the Board of Directors and our leadership team, I would like to express our appreciation for your continued support for Privia Health, stated David P. King, Chair of the Board of Directors.

Industry Context

The document highlights the company's commitment to value-based care models, patient experience, and optimizing provider workflow, aligning with broader trends in the healthcare industry.

Comparison to Industry Standards

• The document mentions a peer group of publicly traded companies similarly situated in size and industry profile to Privia Health, including Accolade, Inc., Goodrx Holdings, Inc., Phreesia, Inc., Agilon Health, Inc., Health Catalyst, Inc., Premier, Inc., Alignment Healthcare, Inc., Health Equity, Inc., Oscar Health, Inc., Astrana Health, Inc., Lifestance Health Group, Inc., Surgery Partners, Inc., Evolent Health, Inc., Claritev Corporation (f/k/a Multiplan Corporation), and Teladoc Health, Inc.
• The document mentions the company uses the Nasdaq Health Care Index (the Health Care Index) as the peer group for presenting a comparison of total shareholder return (TSR).

Management Changes

Corporate Governance

Related Party Transactions

• The document mentions a registration rights agreement with certain indirect beneficial owners of greater than 1% of the common stock, including the former lead investors, Bill Sullivan, Shawn Morris and Parth Mehrotra, among others.

Stakeholder Impact

• The proposals outlined in the proxy statement will impact stockholders through their voting rights and influence on company governance.
• The company's commitment to corporate responsibility and sustainability aims to create long-term value for its business, stockholders, and society.
• The company's focus on value-based care models and patient experience impacts patients, providers, and the healthcare system as a whole.
• The company's commitment to its employees is reflected in its employee experience and engagement programs.

Next Steps

• Stockholders are encouraged to vote on the proposals outlined in the proxy statement.
• The company will continue its cycle of year-round stockholder engagement, including regular participation in investor meetings and conferences and periodic engagement on corporate governance and compensation topics.

Key Dates

Keywords

Annual Meeting, Stockholders, Board of Directors, Proxy Statement, Director Election, Executive Compensation, PricewaterhouseCoopers, Corporate Governance, Independent Directors, Audit Committee, Compensation Committee, Compliance Committee, Risk Oversight, Related Party Transactions, Sustainability, Cybersecurity, Stock Ownership Guidelines, Clawback Policy, Privia Health